Blood culture 101 - Best practices from pre-analytical to post-analytical phases in blood culture testing

On-demand webinar

Sepsis represents a substantial healthcare and economic burden worldwide, and remains a leading cause of death in the United States.1 Due to the high morbidity and mortality associated with sepsis, blood culture and associated diagnostics for bloodstream infections must be accurate and efficient to correctly inform treatment decisions.

Join our experts as they discuss actionable steps to implement in each phase of the diagnostic pathway and strategies to improve the diagnostic accuracy and efficiency of your blood culture tests.

Register today!

Featured Speakers

Placeholder

Patrick Murray, PhD
VP, WW Scientific Affairs
BD Life Sciences

Dr. Patrick R. Murray received his Ph.D. degree in Microbiology at UCLA, postgraduate training in Clinical Microbiology at the Mayo Clinic in Rochester MN, and was director of the Clinical Microbiology Laboratories at Barnes-Jewish Hospital and Professor of Medicine and Pathology at Washington University from 1976-1999. In 1999, he joined the faculty of the University of Maryland School of Medicine and in 2001, he accepted the position of Senior Scientist and Chief of Microbiology at the National Institutes of Health (NIH).

In July 2011, he retired from the NIH and accepted his current position at BD Diagnostics as Vice President, Worldwide Scientific Affairs. He is a fellow of the American Academy of Microbiology and the Infectious Disease Society of America, member of the CLSI Consensus Committee for Antimicrobial Susceptibility Test Standards, former Chairman of the American Board of Medical Microbiology, former Editor-in-Chief of the ASM Manual of Clinical Microbiology from 1990 to 2010, former Editor of the Journal of Clinical Microbiology, and currently serves on numerous editorial boards. He has authored more than 275 research articles and 20 books.

He is the recipient of numerous awards including the ASM Award for Research in Clinical Microbiology (1993), ASM Award for Leadership in Clinical Microbiology (2002), ASM Founders Distinguished Service Award (2010), and ABMM/ABMLI Professional Recognition Award (2011), as well as the Pasteur Lifetime Achievement Award (2007), NIH Clinical Center Director's Awards for Patient Care (2006) and Research (2010), and NIH Director's Award for Research (2007).

Placeholder

Sol F. Green, PhD, FAACC
Director, Medical Affairs
BD Life Sciences
Assistant Professor of Clinical Pathology, Stony Brook School of Medicine

Dr. Green has over 25 years clinical research experience in fields of Laboratory Medicine, including preanalytical variability and errors, clinical chemistry and automation, blood pH and gases, endocrinology, therapeutic drug monitoring, toxicology, special chemistry and cardiac markers. He is a fellow of the AACC Academy, and has a Certificate of Qualification as a Clinical Laboratory Director in New York State. He has been responsible for oversight of the BD Preanalytical Systems Department of Medical Affairs in Europe, Middle East and Africa as well as North and South America. Currently he is the US Medical Director and Director of Global Technical Services.

Dr. Green’s leadership experience in professional organizations relevant to clinical practices and standards include: The European Preanalytical Scientific Committee member, International Federation of Clinical Chemistry and Laboratory Medicine – Corporate member, American Association of Clinical Chemistry – Corporate member and Scientific Advisory Board, American Association of Clinical Chemistry – Academic Council member, Association of Clinical Scientist – Scientific Council, Clinical Laboratory and Analytical Sciences – Section Executive Committee and Past Chair, American Association of Clinical Chemistry – Section Executive Committee and Past Chair and member of the American Chemical Society. Dr. Green has over 60 publications including 5 book chapters and 5 patents relevant to preanalytical clinical devices.

Placeholder

Prof. Hossam Abdel Ghaffar, MD

Secretary of the Supreme Council of Hospitals, Egypt

Placeholder

Danial Kimani, MD

Public Health Specialist, Centers for Disease Control and Prevention (CDC), Kenya

Placeholder

Prof. Hossam Abdel Ghaffar, MD

Secretary of the Supreme Council of Hospitals, Egypt

Placeholder

Danial Kimani, MD

Public Health Specialist, Centers for Disease Control and Prevention (CDC), Kenya

Placeholder

Improving healthcare workplace safety is critical to both care providers and their patients

Improving healthcare workplace safety is critical to both care providers and their patients

Uscid est ad quis et lam sitatium commoloribus solupta illaborum doloria alisci dioribus si quis porereh enianimus mollam, quo maxim quis ma senimus, alit,Deles etusapici am, inusdae commodi cupiderro doluptas acipsap elignatio omnihilla inihiliciu Denihit doluptamus ut ped ut eatinie ndandem. Quae. Olut exerios dipsum nis

Used by more than 1000 oncology facilities

BD offers a complete closed system drug transfer device (CSTD) portfolio to help reduce the risk of staff exposure to hazardous drugs.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Placeholder

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Save Your Seat

REFERENCES

1. Sepsis Alliance Fact Sheet May 15, 2017 

BD is committed to keeping your personal data protected and secure. More information on how we protect your personal data can be found in our privacy statement and our cookie policy.

Contact us | Unsubscribe | My profile